Symbol
IPA
Investment type
Equity / Common Shares, no par value
Latest Disclosed Shares Owned
1,828,365 shares
Security Ownership %
5.8%

Charmquark TWEE ownership in ImmunoPrecise Antibodies Ltd. Common Shares, no par value (IPA)

24 Jan 2025 - Charmquark TWEE has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,828,365 shares of ImmunoPrecise Antibodies Ltd. Common Shares, no par value (IPA). This represents 5.8% ownership of the company. This is the first filing by Charmquark TWEE disclosing ownership of ImmunoPrecise Antibodies Ltd. Common Shares, no par value (IPA).